Survivors of gynecologic malignancies: Impact of treatment on health and well-being
Identifieur interne : 007715 ( Ncbi/Merge ); précédent : 007714; suivant : 007716Survivors of gynecologic malignancies: Impact of treatment on health and well-being
Auteurs : Shannon N. Westin [États-Unis] ; Charlotte C. Sun [États-Unis] ; Celestine S. Tung [États-Unis] ; Robin A. Lacour [États-Unis] ; Larissa A. Meyer [États-Unis] ; Diana L. Urbauer [États-Unis] ; Michael M. Frumovitz [États-Unis] ; Karen H. Lu [États-Unis] ; Diane C. Bodurka [États-Unis]Source :
- Journal of cancer survivorship : research and practice [ 1932-2259 ] ; 2015.
Abstract
While overall survival from gynecologic malignancies has greatly improved over the last 3 decades, required treatments can lead to multiple health issues for survivors. Our objective was to identify health concerns that gynecologic cancer survivors face.
A systematic, stratified sample of women with gynecologic malignancies was surveyed for 18 health issues occurring before, during, or after treatment. The impact of clinical features and treatment modality on health issues was assessed through multivariate logistic regression models.
Of 2,546 surveys mailed, 622 were not received by eligible subjects secondary to invalid address, incorrect diagnosis, or death. Thus, 1,924 survivors potentially received surveys. Of the 1,029 surveys (53.5%) completed, median age was 59 years; diagnoses included 29% cervical, 26% endometrial, 26% ovarian/primary peritoneal/fallopian tube, 12.1% vulvar, and 5.4% vaginal cancers. The most frequently reported health issues included: fatigue (60.6%), sleep disturbance (54.9%), urinary difficulties (50.9%), sexual dysfunction (48.4%), neurologic issues (45.4%), bowel complaints (42.0%), depression (41.3%), and memory problems (41.2%). These rankings were consistent with patients’ self-reported rankings of “highest impact” personal issues. After controlling for demographic and clinical variables, multivariate analyses revealed treatment modality impacted the odds of experiencing a given health issue.
Our study demonstrates gynecologic cancer survivors experience a high frequency of health conditions and highlights the association between treatment modality and specific health concerns.
The study findings highlight the multiple health concerns experienced by gynecologic cancer survivors and suggest the potential for developing interventions to mitigate these concerns in survivorship.
Url:
DOI: 10.1007/s11764-015-0472-9
PubMed: 26245979
PubMed Central: 4744585
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003549
- to stream Pmc, to step Curation: 003548
- to stream Pmc, to step Checkpoint: 000E44
Links to Exploration step
PMC:4744585Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Survivors of gynecologic malignancies: Impact of treatment on health and well-being</title>
<author><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N." last="Westin">Shannon N. Westin</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sun, Charlotte C" sort="Sun, Charlotte C" uniqKey="Sun C" first="Charlotte C." last="Sun">Charlotte C. Sun</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tung, Celestine S" sort="Tung, Celestine S" uniqKey="Tung C" first="Celestine S." last="Tung">Celestine S. Tung</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lacour, Robin A" sort="Lacour, Robin A" uniqKey="Lacour R" first="Robin A." last="Lacour">Robin A. Lacour</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Louisiana State University Health Sciences Center – Shreveport, Department of Obstetrics and Gynecology, Shreveport, LA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Louisiane</region>
</placeName>
<wicri:cityArea>Louisiana State University Health Sciences Center – Shreveport, Department of Obstetrics and Gynecology, Shreveport</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meyer, Larissa A" sort="Meyer, Larissa A" uniqKey="Meyer L" first="Larissa A." last="Meyer">Larissa A. Meyer</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Urbauer, Diana L" sort="Urbauer, Diana L" uniqKey="Urbauer D" first="Diana L." last="Urbauer">Diana L. Urbauer</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Frumovitz, Michael M" sort="Frumovitz, Michael M" uniqKey="Frumovitz M" first="Michael M." last="Frumovitz">Michael M. Frumovitz</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lu, Karen H" sort="Lu, Karen H" uniqKey="Lu K" first="Karen H." last="Lu">Karen H. Lu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bodurka, Diane C" sort="Bodurka, Diane C" uniqKey="Bodurka D" first="Diane C." last="Bodurka">Diane C. Bodurka</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26245979</idno>
<idno type="pmc">4744585</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744585</idno>
<idno type="RBID">PMC:4744585</idno>
<idno type="doi">10.1007/s11764-015-0472-9</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">003549</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003549</idno>
<idno type="wicri:Area/Pmc/Curation">003548</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003548</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000E44</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E44</idno>
<idno type="wicri:Area/Ncbi/Merge">007715</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Survivors of gynecologic malignancies: Impact of treatment on health and well-being</title>
<author><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N." last="Westin">Shannon N. Westin</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sun, Charlotte C" sort="Sun, Charlotte C" uniqKey="Sun C" first="Charlotte C." last="Sun">Charlotte C. Sun</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tung, Celestine S" sort="Tung, Celestine S" uniqKey="Tung C" first="Celestine S." last="Tung">Celestine S. Tung</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lacour, Robin A" sort="Lacour, Robin A" uniqKey="Lacour R" first="Robin A." last="Lacour">Robin A. Lacour</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Louisiana State University Health Sciences Center – Shreveport, Department of Obstetrics and Gynecology, Shreveport, LA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Louisiane</region>
</placeName>
<wicri:cityArea>Louisiana State University Health Sciences Center – Shreveport, Department of Obstetrics and Gynecology, Shreveport</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meyer, Larissa A" sort="Meyer, Larissa A" uniqKey="Meyer L" first="Larissa A." last="Meyer">Larissa A. Meyer</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Urbauer, Diana L" sort="Urbauer, Diana L" uniqKey="Urbauer D" first="Diana L." last="Urbauer">Diana L. Urbauer</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Frumovitz, Michael M" sort="Frumovitz, Michael M" uniqKey="Frumovitz M" first="Michael M." last="Frumovitz">Michael M. Frumovitz</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lu, Karen H" sort="Lu, Karen H" uniqKey="Lu K" first="Karen H." last="Lu">Karen H. Lu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bodurka, Diane C" sort="Bodurka, Diane C" uniqKey="Bodurka D" first="Diane C." last="Bodurka">Diane C. Bodurka</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of cancer survivorship : research and practice</title>
<idno type="ISSN">1932-2259</idno>
<idno type="eISSN">1932-2267</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Purpose</title>
<p id="P1">While overall survival from gynecologic malignancies has greatly improved over the last 3 decades, required treatments can lead to multiple health issues for survivors. Our objective was to identify health concerns that gynecologic cancer survivors face.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A systematic, stratified sample of women with gynecologic malignancies was surveyed for 18 health issues occurring before, during, or after treatment. The impact of clinical features and treatment modality on health issues was assessed through multivariate logistic regression models.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Of 2,546 surveys mailed, 622 were not received by eligible subjects secondary to invalid address, incorrect diagnosis, or death. Thus, 1,924 survivors potentially received surveys. Of the 1,029 surveys (53.5%) completed, median age was 59 years; diagnoses included 29% cervical, 26% endometrial, 26% ovarian/primary peritoneal/fallopian tube, 12.1% vulvar, and 5.4% vaginal cancers. The most frequently reported health issues included: fatigue (60.6%), sleep disturbance (54.9%), urinary difficulties (50.9%), sexual dysfunction (48.4%), neurologic issues (45.4%), bowel complaints (42.0%), depression (41.3%), and memory problems (41.2%). These rankings were consistent with patients’ self-reported rankings of “highest impact” personal issues. After controlling for demographic and clinical variables, multivariate analyses revealed treatment modality impacted the odds of experiencing a given health issue.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Our study demonstrates gynecologic cancer survivors experience a high frequency of health conditions and highlights the association between treatment modality and specific health concerns.</p>
</sec>
<sec id="S5"><title>Implications for Cancer Survivors</title>
<p id="P5">The study findings highlight the multiple health concerns experienced by gynecologic cancer survivors and suggest the potential for developing interventions to mitigate these concerns in survivorship.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">101307557</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34604</journal-id>
<journal-id journal-id-type="nlm-ta">J Cancer Surviv</journal-id>
<journal-id journal-id-type="iso-abbrev">J Cancer Surviv</journal-id>
<journal-title-group><journal-title>Journal of cancer survivorship : research and practice</journal-title>
</journal-title-group>
<issn pub-type="ppub">1932-2259</issn>
<issn pub-type="epub">1932-2267</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">26245979</article-id>
<article-id pub-id-type="pmc">4744585</article-id>
<article-id pub-id-type="doi">10.1007/s11764-015-0472-9</article-id>
<article-id pub-id-type="manuscript">NIHMS713591</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Survivors of gynecologic malignancies: Impact of treatment on health and well-being</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Westin</surname>
<given-names>Shannon N.</given-names>
</name>
<degrees>MD,MPH</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Sun</surname>
<given-names>Charlotte C.</given-names>
</name>
<degrees>DrPH</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Tung</surname>
<given-names>Celestine S.</given-names>
</name>
<degrees>MD,MPH</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lacour</surname>
<given-names>Robin A.</given-names>
</name>
<degrees>MD,MPH</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Meyer</surname>
<given-names>Larissa A.</given-names>
</name>
<degrees>MD,MPH</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Urbauer</surname>
<given-names>Diana L.</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Frumovitz</surname>
<given-names>Michael M.</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lu</surname>
<given-names>Karen H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Bodurka</surname>
<given-names>Diane C.</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX</aff>
<aff id="A2"><label>2</label>
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX</aff>
<aff id="A3"><label>3</label>
Louisiana State University Health Sciences Center – Shreveport, Department of Obstetrics and Gynecology, Shreveport, LA</aff>
<aff id="A4"><label>4</label>
Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston, TX</aff>
<author-notes><corresp id="cor1"><label>*</label>
<bold>Corresponding Author</bold>
. Shannon N. Westin, MD, MPH, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362,CPB6.3279, Houston, TX 77030, <email>swestin@mdanderson.org</email>
, Phone: 713-794-4314, Fax: 713-792-7586</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>8</day>
<month>8</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub"><day>06</day>
<month>8</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>10</volume>
<issue>2</issue>
<fpage>261</fpage>
<lpage>270</lpage>
<pmc-comment>elocation-id from pubmed: 10.1007/s11764-015-0472-9</pmc-comment>
<abstract><sec id="S1"><title>Purpose</title>
<p id="P1">While overall survival from gynecologic malignancies has greatly improved over the last 3 decades, required treatments can lead to multiple health issues for survivors. Our objective was to identify health concerns that gynecologic cancer survivors face.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A systematic, stratified sample of women with gynecologic malignancies was surveyed for 18 health issues occurring before, during, or after treatment. The impact of clinical features and treatment modality on health issues was assessed through multivariate logistic regression models.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Of 2,546 surveys mailed, 622 were not received by eligible subjects secondary to invalid address, incorrect diagnosis, or death. Thus, 1,924 survivors potentially received surveys. Of the 1,029 surveys (53.5%) completed, median age was 59 years; diagnoses included 29% cervical, 26% endometrial, 26% ovarian/primary peritoneal/fallopian tube, 12.1% vulvar, and 5.4% vaginal cancers. The most frequently reported health issues included: fatigue (60.6%), sleep disturbance (54.9%), urinary difficulties (50.9%), sexual dysfunction (48.4%), neurologic issues (45.4%), bowel complaints (42.0%), depression (41.3%), and memory problems (41.2%). These rankings were consistent with patients’ self-reported rankings of “highest impact” personal issues. After controlling for demographic and clinical variables, multivariate analyses revealed treatment modality impacted the odds of experiencing a given health issue.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Our study demonstrates gynecologic cancer survivors experience a high frequency of health conditions and highlights the association between treatment modality and specific health concerns.</p>
</sec>
<sec id="S5"><title>Implications for Cancer Survivors</title>
<p id="P5">The study findings highlight the multiple health concerns experienced by gynecologic cancer survivors and suggest the potential for developing interventions to mitigate these concerns in survivorship.</p>
</sec>
</abstract>
<kwd-group><kwd>Gynecologic Malignancy</kwd>
<kwd>Survivorship</kwd>
<kwd>Health Issues</kwd>
<kwd>Quality of Life</kwd>
<kwd>Treatment</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Louisiane</li>
<li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N." last="Westin">Shannon N. Westin</name>
</region>
<name sortKey="Bodurka, Diane C" sort="Bodurka, Diane C" uniqKey="Bodurka D" first="Diane C." last="Bodurka">Diane C. Bodurka</name>
<name sortKey="Frumovitz, Michael M" sort="Frumovitz, Michael M" uniqKey="Frumovitz M" first="Michael M." last="Frumovitz">Michael M. Frumovitz</name>
<name sortKey="Lacour, Robin A" sort="Lacour, Robin A" uniqKey="Lacour R" first="Robin A." last="Lacour">Robin A. Lacour</name>
<name sortKey="Lu, Karen H" sort="Lu, Karen H" uniqKey="Lu K" first="Karen H." last="Lu">Karen H. Lu</name>
<name sortKey="Meyer, Larissa A" sort="Meyer, Larissa A" uniqKey="Meyer L" first="Larissa A." last="Meyer">Larissa A. Meyer</name>
<name sortKey="Sun, Charlotte C" sort="Sun, Charlotte C" uniqKey="Sun C" first="Charlotte C." last="Sun">Charlotte C. Sun</name>
<name sortKey="Tung, Celestine S" sort="Tung, Celestine S" uniqKey="Tung C" first="Celestine S." last="Tung">Celestine S. Tung</name>
<name sortKey="Urbauer, Diana L" sort="Urbauer, Diana L" uniqKey="Urbauer D" first="Diana L." last="Urbauer">Diana L. Urbauer</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007715 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 007715 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= PMC:4744585 |texte= Survivors of gynecologic malignancies: Impact of treatment on health and well-being }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:26245979" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |